The FDA is on the cusp of deciding whether at least one type of hormonal birth control — a progestin-only drug called Opill by French drugmaker HRA Pharma — is safe enough to be sold over the counter without a prescription and without age restrictions.
Angela Maske manages a team of youth advocates for Free the Pill, a coalition of organizations that advocate for easier access to birth control.Angela Maske was a college freshman in Washington, D.C., when she first had trouble getting a prescription forHer Catholic-affiliated university wouldn't prescribe the medication to students as a sexual contraceptive, so Maske spent three months looking for another doctor's appointment.
Maske now works with Free the Pill, a coalition of advocates that's spent years dedicated entirely to increasing public access to contraception -- a goal they say is critical to people already struggling to access"It's just frustrating because feels like yet another barrier that people have to go through to access essential care to control their reproductive and sexual autonomy," said Maske.
The Food and Drug Administration is on the cusp of deciding whether at least one type of hormonal birth control -- a progestin-only drug called "Opill" by French drugmaker HRA Pharma -- is safe enough to be sold over the counter without a prescription and without age restrictions. FDA's panel of scientific advisers are expected to meet next week to discuss the application, and if the agency signs off the drug in coming weeks, the product could be on shelves this summer.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant PatchXelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.
Read more »
FDA OKs Once-Nightly Sodium Oxybate for NarcolepsyExtended-release sodium oxybate (Lumryz) is taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.
Read more »
FDA Fast Tracks Potential CAR T-Cell Therapy for LupusThe cellular therapy depletes CD19-positive B cells with the goal of 'resetting' the immune system to achieve durable remission.
Read more »
FDA Does Not Require Menstrual Product Ingredients on LabelsNew York and California have passed laws requiring disclosure of ingredients on menstrual product packaging. Advocates want more transparency across the United States.
Read more »
FDA approves world's first RSV vaccine, a shot for adults ages 60 and upBREAKING: FDA approves the world's first respiratory syncytial virus, or RSV, vaccine made by pharmaceutical giant GSK.
Read more »